Cargando…
A practical guide to managing hypertension, hyperlipidemia, and hyperglycemia in patients with chronic myeloid leukemia
Tyrosine kinase inhibitors (TKIs) have significantly improved the prognosis of chronic myeloid leukemia (CML) since their approval. Although safe in general, TKIs carry concerns about cardiovascular adverse events. Hypertension, diabetes, and dyslipidemia are among the most common baseline comorbidi...
Autores principales: | Ahmed, Khalid, Kaddoura, Rasha, Yassin, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774492/ https://www.ncbi.nlm.nih.gov/pubmed/36569145 http://dx.doi.org/10.3389/fmed.2022.1025392 |
Ejemplares similares
-
A practical guide to managing cardiopulmonary toxicities of tyrosine kinase inhibitors in chronic myeloid leukemia
por: Kaddoura, Rasha, et al.
Publicado: (2023) -
Applications of Machine Learning in Chronic Myeloid Leukemia
por: Elhadary, Mohamed, et al.
Publicado: (2023) -
Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report
por: Yasin, Ahmed K, et al.
Publicado: (2023) -
SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study
por: Ali, Elrazi A, et al.
Publicado: (2022) -
Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report
por: Waseem Hajjar, Adnan Humam, et al.
Publicado: (2022)